Status:
COMPLETED
Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer
Lead Sponsor:
Virginia Commonwealth University
Conditions:
Breast Cancer
Eligibility:
FEMALE
21-81 years
Brief Summary
This study examines the relationship among epigenetic alterations and the development and persistence of psychoneurologic symptoms (cognitive dysfunction, depressive symptoms, anxiety, fatigue, sleep ...
Detailed Description
Advancements in breast cancer have resulted in increased survival rates; however, many women with breast cancer experience distressing symptoms. Inflammatory activation and epigenetic alterations have...
Eligibility Criteria
Inclusion
- At least 21 years of age
- Diagnosed with stage I to IIIa Breast Cancer
- Scheduled to receive chemotherapy
Exclusion
- previous cancer history
- previous chemotherapy history
- dementia
- active psychosis
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01411943
Start Date
January 1 2011
End Date
July 1 2015
Last Update
December 8 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Peninsula Cancer Institute
Newport News, Virginia, United States, 23601
2
Virginia Commonwealth University
Richmond, Virginia, United States, 23298